Portable Ultrasound Monitoring for Premature Infant Monitoring
(POCUS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if portable ultrasound devices can help nurses quickly monitor premature babies between 24 and 32 weeks of gestation. The trial compares two methods: continuous fetal monitoring (the usual method) and a handheld ultrasound device. Researchers seek pregnant women carrying a single baby within this gestational age range. Participants will help determine if the portable ultrasound method is faster and more efficient than the standard approach. As an unphased trial, this study offers participants the chance to contribute to innovative research that could enhance monitoring techniques for premature babies.
Do I have to stop taking my current medications for the trial?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that portable ultrasound devices are safe for premature infant monitoring?
Research has shown that handheld ultrasound devices used at the point of care are generally safe and non-invasive. Doctors commonly use these devices in emergency rooms and intensive care units to diagnose and treat patients more quickly. However, detailed information about their safety specifically for newborns remains limited.
Overall, portable ultrasound is considered safe, with no major side effects reported. This makes it a promising tool for monitoring babies without causing harm.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to enhance fetal monitoring for premature infants. Traditional methods like continuous fetal monitoring (cEFM) involve stationary machines that may not provide real-time flexibility. However, the trial's experimental method uses a Point of Care Handheld Ultrasound. This portable device allows nurses to quickly locate and monitor the fetal heart, potentially making the process faster and more adaptable in various settings. By combining this handheld technology with cEFM, the trial aims to improve the efficiency and effectiveness of fetal monitoring, offering a promising advance over current standard practices.
What evidence suggests that using portable ultrasound devices is effective for premature infant monitoring?
Research shows that Point of Care Handheld Ultrasound, one method studied in this trial, promises faster and more accurate monitoring. Studies indicate it effectively provides quick bedside images, especially useful in NICUs (Neonatal Intensive Care Units). This method helps nurses locate the baby's heart swiftly, speeding up the connection to monitoring devices. Evidence-based guidelines support its use for very sick newborns, suggesting it can enhance care. This approach is gaining popularity because it reduces wait times and improves monitoring accuracy, crucial for premature babies. Meanwhile, Continuous Fetal Monitoring, another method under study, remains a standard practice for fetal monitoring.34678
Are You a Good Fit for This Trial?
This trial is for pregnant women aged 18 to 50 with a single baby between 24 and 32 weeks of gestation. It's not suitable for those outside this pregnancy window, under age 18, if the fetus has a known lethal anomaly where monitoring was declined, or if they are incarcerated.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Nurses use handheld ultrasound devices to assist with applying continuous external fetal monitoring (cEFM) in early preterm pregnancies
Follow-up
Participants are monitored for the time to successful detection of fetal heart rate and any need for physician intervention
What Are the Treatments Tested in This Trial?
Interventions
- Continuous Fetal Monitoring
- Point of Care Handheld Ultrasound
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Texas Medical Branch, Galveston
Lead Sponsor